Quick Answer
Pharmagreen Biotech Inc. reported Total Assets of $209.0 thousand for fiscal year 2022.
Pharmagreen Biotech Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2022 | $209.0K | -44.0% |
| 2021 | $373.1K | +40.1% |
| 2020 | $266.2K | -57.8% |
| 2019 | $630.3K | +40.2% |
| 2018 | $449.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | $140.3K | -26.6% | -13.9% |
| March 31, 2023 | $163.0K | -17.9% | -23.0% |
| December 31, 2022 | $211.7K | -40.8% | +1.3% |
| September 30, 2022 | $209.0K | -44.0% | +9.3% |
| June 30, 2022 | $191.2K | +890.2% | -3.6% |
| March 31, 2022 | $198.4K | +1340.2% | -44.5% |
| December 31, 2021 | $357.8K | — | -4.1% |
| September 30, 2021 | $373.1K | +40.1% | +1832.5% |
- Pharmagreen Biotech Inc. showed a decrease of -44.0% in Total Assets compared to the prior fiscal year.
- Over the 2018–2022 period, Pharmagreen Biotech Inc.’s total assets has declined by 53.5% (from $449.4 thousand to $209.0 thousand).
- The most recent figure is from Pharmagreen Biotech Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on January 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: